Lexology December 30, 2025
Hall Render Killian Heath & Lyman PC

On Tuesday, December 30, 2025, the Drug Enforcement Administration (“DEA”) and the Department of Health and Human Services (“HHS,” and together with the DEA, the “Agencies”) issued a fourth temporary rule (the “Fourth Temporary Rule”) extending the COVID-19-era telemedicine flexibilities for prescribing Schedule II–V controlled substances through...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Govt Agencies, HHS, Patient / Consumer, Provider, Technology, Telehealth
Telehealth Claims Are Declining, What’s Next For Virtual Mental Health Care?
The telehealth trap: Why single-service roles lead to burnout
2026 Telehealth Predictions: Multidisciplinary Experts Weigh In
Determinants of The Willingness to Adopt Telehealth Technology Among Health Professionals in a Tertiary Hospital
ATA updates AI policy principles

Share Article